Vaccine Harms: Reports by Vaccine Type
Quick access to verifiable sources, organized by vaccine type.
Contents
Vaccines: Corruption from Every Angle
Reports by Vaccine Type (Excerpts): Scroll down to see excerpts from reports by vaccine type. Or select links in this list to focus on that particular vaccine:
Anthrax, Swine Flu, Mpox, Smallpox, TB, Other
Cancer Vaccines
Vaccines: Corruption from Every Angle
Select from the following organized view for quick access to more than 600 reports on verifiable harms caused by the corrupt vaccine business.
Corruption & Fraud link
Serious Harms link
“Safety Testing” link
Propaganda, Censorship link
SIDS, Infant Mortality link
Heavy Metals, Other Neurotoxins link
Pharma’s Cash Cow: Vaccine Schedule + Liability Protection link
Smallpox History link
Reports by Vaccine Type link (you’re here)
Reports by Vaccine Type (Excerpts)
Gardasil, HPV
HPV = Human Papillomavirus; Cervical Cancer
Image source: Fox News here
‘Stunning Admission’: Widely Used HPV Vaccine Linked to 4 Autoimmune Disorders: A study comparing nearly 2 million vaccinated and unvaccinated adolescent girls over 10 years found the girls vaccinated with a quadrivalent HPV vaccine were 4.4 times more likely than their unvaccinated counterparts to develop rheumatoid arthritis.
According to a court document obtained by The Defender, Merck cherry-picked vaccine injury data to prove its Gardasil HPV vaccine didn’t cause serious neurological side effects, and the FDA and CDC replicated Merck’s data selection methods for their own study drawing the same conclusion.
Brenda Baletti PhD, March 2025
The following cases were documented by doctors, medical papers, and filmmakers. Their diligent work allows us to be able to put them together and systematically analyze the mechanisms of injury associated with the HPV vaccines.
Dr. Yuhong Dong MD, PhD, Undeniable Severe Injuries After HPV Vaccination, Sept 2023
Merck, FDA Knew Gardasil HPV Vaccine Was Contaminated With DNA: Newly declassified documents in the landmark lawsuit against Merck reveal that Merck and the FDA knew the vaccine maker didn’t conduct proper testing for DNA contamination, but covered it up.
Maryanne Demasi PhD, February 2025
Two decades ago, Merck pushed Vioxx, a lucrative NSAID onto the market despite knowing it would cause a large number of heart attacks. Merck eventually faced so many lawsuits they had to withdraw it, at which point they rushed, Gardasil, a lucrative HPV vaccine to market to cover their losses. Gardasil was extremely dangerous. However, just like Vioxx, both Merck and the FDA ignored that data, and did all they could to promote it. This continued even after Gardasil brought forward a wave of crippling injuries, unlike anything that had previously been seen for a vaccine. Remarkably many of Gardasil’s issues (e.g., autoimmunity, POTS, infertility, death) are identical to those seen with the Covid-19 vaccines. In turn, there are remarkable parallels to how they were approved (e.g., doctored trials covered up vaccine injuries) and how far the FDA and CDC went to protect those products from scrutiny.
See also: Big Pharma's Immoral Business Model
If you have a daughter approaching the age of 12-14, she will soon be adamantly encouraged, by the attending nurse at her school, and by your very own family doctor, when you are out of the office, to receive the Gardasil HPV vaccine, behind your back... Inexplicably, this dangerous vaccine contains L-histidine, an essential amino acid, which plays a vital role in pregnancy; the synthetic form of which can also pass through the placental wall to the fetus. This could be the direct cause to the spontaneous miscarriage and birth defects in some of the babies. Whenever a vital, naturally occurring substance such as L-histidine is injected into the body subcutaneously or intramuscularly (alongside heavy metals, live/attenuated viruses, detergents & antibiotic excipients etc), a counter effect inevitably occurs where-in the immune system cannot differentiate between the naturally occurring amino acid in the body from that present in the vaccine; registering all these intruders as a common enemy of toxic debris. The immune system instinctively kicks into overdrive, alerting any available antibodies throughout the body to identify & eliminate deposits of L-histidine it encounters in its path. The end result, in each case, we’re seeing the antithesis of nature’s course develop, as the body, stripped of one or more primary components, is now, in essence, at war with itself. What follows is cascade of unfortunate auto-immune reactions; neurological & neuro-developmental breakdown.
The CDC reports that more than 12 percent of American women – one in eight—have trouble conceiving and bearing a child. Male fertility is plunging, too, and the trend is global. Something – or things — are robbing young women and men of their capacity to procreate... Earlier this month, when an unprecedented study was released that looked at a database of more than eight million American women and singled out a whopping 25 percent increase in childlessness associated with one ubiquitous drug that young women have been taking for only a decade — in tandem with a marked decline in fecundity — you would have thought there would be significant interest from public health, the medical profession and the media, wouldn’t you?... The study, published in the current Journal of Toxicology and Environmental Health, examines the childbearing capacity of women who received the human papilloma virus (HPV) vaccine – compared to those who didn’t — and the results are chilling. No one in public health, medicine or mainstream media, which are tangled up in the money-making machine of this vaccine, dare to publicly question the “safe and effective” mantra they’ve promulgated about Merck and GSK pharmaceuticals’ “blockbuster” commodity worth billions.
Celeste McGovern, November 2018
This is the seventh Gardasil lawsuit Baum Hedlund and I have filed against Merck challenging the company’s dangerous and defective HPV vaccine for causing severe and life changing injuries. In addition to Kayla’s case filed this week, we have filed cases on behalf of Michael Colbath of California, Sahara Walker of Wisconsin, Zach Otto of Colorado, Julia Balasco of Rhode Island and two others. While each case is unique, they share common threads: All of our clients were happy, healthy, bright, active kids with unlimited potential until they received the Gardasil HPV vaccine.
Gardasil HPV Vaccine
See here for more details and a list of references by date.
Hep B
Hepatitis B
“The hepatitis B vaccine is a case study in agency capture.”
The hepatitis B vaccine is a case study in agency capture. The target for this product was sex workers and intravenous drug users, and the rare pregnant mother who was hepatitis B positive. The problem was that CDC could not get the sex workers and intravenous drug users to take this product. The story would have ended there if pharma didn’t stand to earn billions through a wider mandate of this product. With those billions at stake, an argument was made that if all newborns were vaccinated (not just the tiny number whose mothers were hepatitis B positive) then we could catch these babies before they became prostitutes or heroin addicts. CDC’s advisory committee, stacked with individuals receiving funding from pharma, added it to the routine childhood schedule in 1995.
Aluminum, a heavy metal and neurotoxin, is injected into babies on their first day of life.
A recent randomized controlled trial by Greenberg et al… linked vaccinations to increased episodes of apnea (temporary cessation of breathing) in premature infants in the NICU, raising questions about the safety and timing of immunizations in this population. One vaccine in question is HepB, which carries a 250 mcg dose of aluminum hydroxide via injection on Day 1 of life.
James Lyons-Weiler PhD, Jan 7, 2025
It’s not been proven to be more beneficial than risky for an infant to get a Hep B vaccine.
There was never any direct evidence that Day 1 medical procedure performed on millions of individual infants had a proper benefit-to-the-individual: risk-to-the-individual ratio. There still is none. The toxicity of aluminum hydroxide is per body-weight dose dependent. Yet studies of chronic illness in infants vaccinated on Day 1 vs Day 180 also do not exist.
James Lyons-Weiler PhD, Aug 14, 2025
Routine Hep B vaccination for infants is nonsensical.
Among the 76 vaccine doses on the schedule, the CDC recommends that every infant born in the U.S. get their first dose of the Hep B vaccine on the day they are born… Hepatitis B is a liver disease caused by the hepatitis B virus. which can range from a mild, short-term, acute illness lasting a few weeks to a serious, long-term, chronic infection. The virus is transmitted through bodily fluids, most often via intimate contact such as sex or sharing intravenous (IV) drug equipment. Being an IV drug user is the most common risk factor for the disease. Infected pregnant mothers can also pass the disease to their infants, but relatively few do — about 25,000 pregnant women per year, or 0.69%, have Hep B, and about 1,000 of them pass it to their babies, according to the HHS. The CDC says, “almost all children and older adults infected with acute HBV recover completely with no lasting liver damage.”
Safety studies were “pathetic.”
The safety studies that were done for the two different brands of Hepatitis B vaccine—Engerix-B and Recombivax HB—were so pathetic in terms of the duration of post-injection safety review as to render them utterly useless. Most people don’t believe me when I explain this to them, which is why I’m going to share the package inserts with the two vaccines with you right now.
“Pathetic” is not an exaggeration. Some “clinical trials” studied “safety” for four days… how can that even be called a clinical trial?
The safety data on Recombivax HB, the hepatitis B vaccine for newborns, are sadly lacking, as the FDA approved the shot based on clinical trials performed on only 147 infants and children and followed for only five days. There are four hepatitis B vaccines, two of which are approved for infants; the second approved for infants is Engerix-B, and clinical safety data show infants and children were followed for only four days in these trials. Most infants are not at high risk for hepatitis B. It makes better financial and health sense to test mothers before birth and vaccinate only those infants born to mothers with an active or chronic hepatitis B infection, putting off vaccination in other infants until they are older. The current childhood vaccination schedule includes 19 potential doses of vaccines and one mRNA experimental injection by the time an infant is 6 months old. Many of these contain aluminum, which raises a child’s risk of persistent asthma in childhood.
Journal report: 12-year-old died after third hepatitis B vaccine.
Hep B Vaccine
See here for more details and a list of references by date.
RSV Vaccine, Monoclonal Antibody Clesrovimab, Nirsevimab, Enflonsia, Abrysvo, Arexvy
Respiratory Syncytial Virus
In June 2025, the FDA Approved an RSV Shot for Newborns that Caused Serious Neurological Conditions and Death
FDA greenlights Merck’s RSV shot for newborns — clinical trials showed 12% rate of serious adverse events, including death. The antibody shot will be marketed as Enflonsia and launched this coming RSV season to challenge Sanofi and AstraZeneca’s blockbuster Beyfortus shot. The drug’s clinical trial results posted on ClinicalTrials.gov included serious neurological adverse reactions.
CDC’s Approval of RSV Monoclonal Antibody Was Based on Data Manipulation that Hid the Statistical Significance of Seizures in Babies
One of the most significant items on the agenda was whether to recommend Merck’s new RSV monoclonal antibody, clesrovimab, for routine use in healthy newborns. Though marketed as a new product, it is nearly identical in structure and function to Sanofi–AstraZeneca’s nirsevimab, approved in 2023… ACIP members were shown a safety slide from the CDC’s Vaccine Safety Datalink focusing on seizures after administration of nirsevimab. The data were split into two age groups: infants aged 0-37 days and those aged 38 days to under 8 months. Each group showed elevated risk ratios for seizures (3.50 and 4.38, respectively), but both were labeled “not significant.” No pooled analysis was displayed. However, as Dr. Maryanne Demasi later reported, combining the two groups into a single cohort yields a very different picture: a nearly four-fold increase in seizure risk, a result that is statistically significant. That consolidated signal was never presented to the committee. The decision to stratify at 38 days – precisely the point in US schedules when routine infant vaccinations begin – had no clear biological justification, and by dispersing the signal across two smaller groups, it effectively erased the statistical significance.
Yaffa Shir-Raz, Brownstone Institute
Babies Who Received the RSV Shot Were Three Times More Likely to Suffer Severe Neurological Damage Compared to Placebo
Merck’s respiratory syncytial virus (RSV) shot clesrovimab (Enflonsia) was approved even though 12% of babies in the trial experienced serious adverse events, including seizures, brain injury, and death. Infants who got clesrovimab had a 350% higher risk of upper respiratory infections — exactly the type of illness this shot claims to prevent. The injection is given in a single, fixed dose regardless of infant weight, putting smaller, younger babies at greater risk due to disproportionately high exposure. Babies who received the shot had a threefold increase in severe neurological reactions compared to those given a placebo. Only about 25 babies in the U.S. succumb to RSV each year, making the known risks of clesrovimab far outweigh the threat the virus poses to most children.
In Every Trial, More Infants Shot with the RSV Injection Died than in the Control
In every trial, more infant deaths occurred in the treatment groups than in the control arms.
